3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
3
Uterine Cervical Neoplasms
2
Endometrial Neoplasms
2
Eccrine Porocarcinoma
2
Vulvar Neoplasms
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sentinel Lymph Node
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Neoplasm Micrometastasis
1
Melanoma
1
Lymphoma
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Carcinoma, Merkel Cell
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Interventions
Surveys and Questionnaires
5
Magnetic Resonance Spectroscopy
3
Quality of Life
2
Drug Therapy
2
Biopsy
2
trastuzumab deruxtecan
1
Tomography, X-Ray Computed
1
Sentinel Lymph Node Biopsy
1
Restraint, Physical
1
Radiotherapy
1
Radionuclide Imaging
1
Psychiatric Rehabilitation
1
Positron-Emission Tomography
1
Patient Reported Outcome Measures
1
Observation
1
Molecular Diagnostic Techniques
1
Mass Screening
1
Interviews as Topic
1
Immunotherapy
1
Immunohistochemistry
1
Human Papillomavirus DNA Tests
1
Genetic Testing
1
Follow-Up Studies
1
Chromatin Immunoprecipitation Sequencing
1
Blood Specimen Collection
1
Biological Therapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Anus Neoplasms
×
Sentinel Lymph Node Biopsy
×
Clear all
NCT02162641
2015-06-03
R-SeNSAR
The Christie NHS Foundation Trust
Withdrawn